Publication | Open Access
The <scp>NRF2</scp> antagonist <scp>ML385</scp> inhibits <scp>PI3K‐mTOR</scp> signaling and growth of lung squamous cell carcinoma cells
41
Citations
57
References
2022
Year
Our data provide additional support for NRF2 promoting LUSC growth through PI3K-mTOR activation and support development of NRF2 inhibitors for the treatment of LUSC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1